Social Media Intervention to Promote Smoking Treatment Utilization and Cessation among Alaska Native Smokers

项目总结 本申请是NIDA资助的R34补助金的行政补充(PA-18-591) 在阿拉斯加本土吸烟者中促进吸烟治疗、利用和戒烟的干预措施“(R34 DA46008)。它响应NIDA的特殊利益通知，NOT-DA-20-047，并符合所述 目的了解新冠肺炎(如焦虑、社交隔离)对成瘾的广泛影响 治疗和物质使用。母公司R34赠款是一项第一阶段治疗发展赠款，旨在开发和 对全州范围内的吸烟者进行Facebook(FB)干预的试点测试。随着新冠肺炎大流行的到来， 现在，社交媒体等虚拟选择比以往任何时候都更有希望成为可持续和可扩展的选择 促进阿拉斯加原住民获得戒烟治疗的干预战略， 以及其他弱势和服务不足的健康差距群体，他们承受着不成比例的 与烟草相关的发病率/死亡率以及受新冠肺炎影响的人群也可能不成比例。在这 补充，我们建议调整和评估新内容对FB干预的感知有效性 与新冠肺炎和吸烟相关，使用严格的参与式方法，就像在开发其他 内容。我们还将收集自我报告的新冠肺炎对我们的治疗结果影响的数据 在我们正在进行的试点临床试验中的使用和停止。我们的具体目标(在范围、时间表和 当前R34)的当前评估流程是：1)评估社交媒体的感知有效性 新冠肺炎上的内容和交流与吸烟(N=40)。我们将在新冠肺炎上使用现有内容 (例如，疾控中心提示™活动视频)以供改编。新冠肺炎消息的潜在内容调整 这可能会影响治疗的利用和戒烟，因为障碍或促进者包括压力、焦虑、感知 风险、社会隔离和社会支持；以及2)探索新冠肺炎感知风险的自我报告影响， 严重性，以及与COVID相关的焦虑、压力、经济影响、社会孤立和社会支持，对我们的 我们正在进行的R34试点临床试验(N=60)中吸烟治疗利用和戒烟的初步结果 6个月随访。我们的措施已经过试点测试，是从新冠肺炎银行中挑选出来的 由美国国立卫生研究院提供的措施。扩展FB干预内容以应对新冠肺炎并进行评估 在母公司R34赠款范围内，新冠肺炎的影响是及时和重大的。这项工作将为 进行更大规模的II期疗效试验。

PROJECT SUMMARY This application is for an administrative supplement (PA-18-591) to NIDA-funded R34 grant “Social Media Intervention to Promote Smoking Treatment Utilization and Cessation among Alaska Native Smokers” (R34 DA46008). It is responsive to the NIDA notice of special Interest, NOT-DA-20-047 and meets the stated objective to understand the broad impacts of COVID-19 (e.g., anxiety, social isolation) on access to addiction treatment and substance use. The parent R34 grant is a Stage I treatment development grant to develop and pilot test a Facebook (FB) intervention for AN smokers statewide. With the advent of the COVID-19 pandemic, now more than ever, virtual options, such as social media, hold promise as sustainable and scalable intervention strategies to promote access to smoking cessation treatment among Alaska Native (AN) people, and other vulnerable and underserved health disparity groups who experience a disproportionate burden of tobacco-related morbidity/mortality and who may also be disproportionately affected by COVID-19. In this supplement, we propose to adapt and evaluate perceived effectiveness of new content for the FB intervention relevant to COVID-19 and smoking, using a rigorous participatory approach, as was done in developing other content. We will also collect data on self-reported impacts of COVID-19 on our outcomes of treatment utilization and cessation within our ongoing pilot clinical trial. Our Specific Aims (within the scope, timeline, and current evaluation process of the current R34) are to: 1) Assess the perceived effectiveness of social media content and communication on COVID-19 and smoking (N=40). We will use existing content on COVID-19 (e.g., CDC Tips™ campaign videos) for adaptation. Potential content adaptations for COVID-19 messaging that may impact treatment utilization and quitting as barriers or facilitators include stress, anxiety, perceived risks, social isolation, and social support; and 2) Explore the self-reported impact of COVID-19 perceived risks, severity, and COVID-related anxiety, stress, financial impacts, social isolation, and social support, on our primary outcome of smoking treatment utilization and cessation in our ongoing R34 pilot clinical trial (N=60) at 6-months follow-up. Our measures have been pilot tested and were selected from a bank of COVID-19 measures provided by the NIH. Expanding FB intervention content to address COVID-19 and evaluating COVID-19 impacts, within the parent R34 grant, is timely and significant. This work will provide the foundation for a larger Stage II efficacy trial.